Followers | 73 |
Posts | 17741 |
Boards Moderated | 2 |
Alias Born | 04/16/2019 |
Tuesday, July 28, 2020 3:00:48 PM
Why did they pay almost 11% in fees?
SECTION 1 - REGISTRANT'S BUSINESS AND OPERATIONS
ITEM 1.01 - ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On July 24, 2020, we entered into a Securities Purchase Agreement (“SPA”) with Power Up Lending Group Ltd., a Virginia corporation (“Purchaser”), pursuant to which we issued and sold to the Purchaser a convertible promissory note, dated July 24, 2020 in the principal amount of $130,000 (the “Note”). We received $116,100 from the investment after the payment of expenses.
The maturity date for the Note is July 24, 2021. The Note bears interest at the rate of 10% per annum. All principal and accrued interest on the Note is convertible into shares of our common stock at the election of the Purchaser after 180 days at 60% of the lowest trading price for our common stock during the 20 trading day period immediately prior to conversion.
We have the right to prepay the Note at any time prior to 180 days following the closing date. The amount we are required to prepay increases from 120% to 140% of the principal amount plus accrued interest and other charges the closer we get to 180 days from closing.
The Note contains customary default events which, if triggered and not timely cured, will result in default interest and penalties.
The foregoing description of the SPA and the Note, and the transactions contemplated thereby does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of the SPA and the Note, which are included in this Current Report as Exhibits 10.1 and 4.1, respectively, and are incorporated herein by reference.
If the Note is converted prior to us paying off such notes under the prepayment provisions, it would lead to substantial dilution to our shareholders as a result of the conversion discounted for the Note. There can be no assurance that there will be any funds available to pay of the Note, or if available, on terms that will be acceptable to us or our shareholders. If we fails to obtain such additional financing on a timely basis, Purchaser may convert the Note and sell the underlying shares, which may result in significant dilution to shareholders due to the conversion discount, as well as a significant decrease in our stock price.
Recent ABQQ News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 08:05:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 08:04:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 06:08:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 05:57:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 07:45:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 05:12:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 04:33:38 PM
- US Airforce Contract Awarded to Epazz, Inc. (OTC Pink: EPAZ) • InvestorsHub NewsWire • 12/14/2023 11:48:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 04:35:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 09:47:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:19:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/30/2023 08:55:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 08:35:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 04:24:58 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 05:57:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 03:53:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 09:24:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/13/2023 09:29:56 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM